AMX0035
- Thread starter anonymous
- Start date
-
- Tags
- None
Company has a strange story. 2 20 yo frat boys started their own company with old generic drugs. Mommy and daddy help fund the company along with ice bucket challenge money. If that’s who we’re worried about then we are fucked
An acquisition would be interesting but how much would you charge for two oral generic products?
They released their press release in December last year. Then silence for 9 months. It’s been about another month of silence since their publication. The FDA has lots of work going on with vaccines. The editorial in NEJM said they need to do a confirmatory trial. They’re going to need to do another trial and to the point above, it’s not clear they can charge much. I assume patients are already using the two components.
One it OTC. One is old generic Rx.
Patients are already using them in combination with one another and other products.
those docs even encouraged the rep to leave for a better opportunity. let that sink in.
"If that drug was available right now, all my patients would get it. There's no question," said Jeffrey Rothstein, director of the Robert Packard Center for ALS Research at the Johns Hopkins University School of Medicine. Rothstein also served as an investigator for the key study of AMX0035, called CENTAUR.”
Can you guess how much Radicava he prescribes?
Can you guess how much Radicava he prescribes?
"If that drug was available right now, all my patients would get it. There's no question," said Jeffrey Rothstein, director of the Robert Packard Center for ALS Research at the Johns Hopkins University School of Medicine. Rothstein also served as an investigator for the key study of AMX0035, called CENTAUR.”
Can you guess how much Radicava he prescribes?
was he part of the radicava trial?